Clinical Trials

Ventricular Tachycardia (VT) Ablation Versus Enhanced Drug Therapy

ClinicalTrials.gov Identifier: NCT00905853

Catheter Ablation Versus Standard Conventional Treatment in Patients With Left Ventricular Dysfunction and Atrial Fibrillation

ANZCTR Trial ID: NCT00643188

Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation

ANZCTR Trial ID: NCT01522898

ProMRI PROVEN Master Study

ANZCTR Trial ID: NCT01809665

Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation

ANZCTR Trial ID: NCT01687166

Page 2 of 3
  • Professor Sanders says...

     
    Atrial fibrillation is a consequence of several reversible risk factors - high blood pressure, diabetes, obesity, sleep apnoea, and excessive alcohol. Your management of atrial fibrillation must include strict control of these risk factors.